A randomised double-blind placebo-controlled crossover trial to assess the effect of ZD4522 [rosuvastatin] on the incorporation of trideuterated leucine into lipid subfractions and apolipoproteins in subjects with mild to moderate hyperlipidaemia
Phase of Trial: Phase III
Latest Information Update: 27 Mar 2006
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 27 Mar 2006 New trial record.